Nordson completes Micromedics acquisition

NewsGuard 100/100 Score

Nordson Corporation (Nasdaq: NDSN) today announced the completion of its acquisition of St. Paul, Minnesota-based Micromedics Inc., a leader in applying and dispensing biomaterials for controlling bleeding, healing wounds and other related medical procedures. Terms of the deal were not disclosed.

"Micromedics extends Nordson's expertise in precision dispensing technology and adds to our growing suite of applications in the expanding medical device and life sciences market," said Nordson President and CEO Michael F. Hilton. "The company is an ideal fit with Nordson's strategy of acquiring high performing market leaders with differentiated technology and significant recurring revenue."

Micromedics bioapplicator products are marketed under the name FibriJet and include single and dual syringe applicators modified with interchangeable tips for the particular needs of specific surgical procedures. The products enable the controlled dispense of a single material or simultaneous dispense of two materials to a localized treatment site with simple, one-handed operation. The products are sold to a wide variety of end customers, including distributors, surgeons, OEMs, hospitals and outpatient clinics.

The acquired business will be integrated into Nordson's Advanced Technology Systems segment. Micromedics product lines related to ear, nose and throat applications and surgical instrument protection were not acquired by Nordson, but will continue to be manufactured and sold as part of a new company called Summit Medical Inc.

SOURCE Nordson Corporation

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Advances and hurdles: The impact of AI on oncology care efficiency and mortality rates